Charles A. Peloquin

ORCID, self-asserted

ORCID 0000-0001-9002-7052

Publications

Citations

214

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

7 works in the graph, newest first.

Population pharmacokinetics of pyrazinamide and ethambutol in children with tuberculosis with or without HIV
2026Antimicrobial Agents and ChemotherapyJournalOpen access0 citations10.1128/aac.00909-25
Pharmacokinetics of Dolutegravir in Children With HIV With and Without Tuberculosis Coinfection Treated According to World Health Organization Dosing Guidelines
2026JAIDS Journal of Acquired Immune Deficiency SyndromesJournalOpen access0 citations10.1097/qai.0000000000003862
Exposure to the four first-line anti-tuberculosis drugs and treatment outcomes: a target trial emulation study in Ghana
2026BMC Infectious DiseasesJournalOpen access0 citations10.1186/s12879-026-14061-4
Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children
2023The International Journal of Tuberculosis and Lung DiseaseJournalOpen access5 citations10.5588/ijtld.22.0591
Pharmacokinetics and pharmacodynamics of adult dolutegravir tablets in treatment-experienced children with HIV weighing at least 20 kg
2023AIDSJournalOpen access2 citations10.1097/qad.0000000000003576
Effect of HIV infection on plasma exposure to first-line TB drugs and target attainment in children
2023The International Journal of Tuberculosis and Lung DiseaseJournalOpen access2 citations10.5588/ijtld.23.0184
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis
2022European Respiratory JournalJournalOpen access37 citations10.1183/13993003.01596-2022